Document is current
Any future updates will be listed below
-
Authors
Llirós Dupré, M.
Buxó, M.
Virolés, S.
Pujolassos, M.
Serra, I.
Martínez, J.
Lluansí, A.
Bahí, A.
Calle, M.
Aldeguer, X.
-
Funding
Funding for this research was provided by:
Societat Catalana de Digestologia (2015 Research Initiation Grant #3)
Joan Bruguera Fund (Girona Townhall, 2017)
- License Information
-
More Information
Article History
Received: 8 January 2026
Accepted: 25 February 2026
First Online: 6 March 2026
Declarations
:
: XA is co-founder of GoodGut S.L. a biotech company, now part of HIPRA® (https://www.hipra.com), characterising the role of gut microbiome in health and disease. The other authors have declared that no competing interests exist.
: The presented research respected the fundamental principles of the Helsinki Declaration and followed all the aspects covered in the Council of Europe and the Convention on Human Rights and Biomedicine as well as the requirements established by the Spanish and Catalan legislation in the field of biomedical research, data protection and bioethics. All participants signed informed consent in compliance with Spanish data protection law (LO 3/2018, of December 5th of 2018 on Protection of personal data and digital rights guarantee (LOPDGDD) and published on December 6th 2018). The institutional review board and ethical committee approved the project on April 2016 (project code: 2016.072).
